OK,
@inadmin ...
Retigabine has been used in the treatment of seizure disorders since 2011 and has been under clinical study in that regard for years prior to its release. Given that 20% of the population has tinnitus, it is reasonable to assume that 20% of the individuals on Retigabine for seizure disorder have tinnitus. Being very conservative and looking only at the 4% of the population suffering from severe intrusive tinnitus, if a substantial percentage of those individuals experienced diminution of their tinnitus on Retigabine, big pharma (which is all about money and profit) would by now already be on it like white on rice.
Is it possible that the fine folks on this board have discovered the holy grail of tinnitus that has been right under big pharma's noses all the time? Sure it is. But in my opinion it's not likely, not considering the gazillions of dollars that big pharma tends to make if there is really anything to it.
Dr. Stephen Nagler
(who would really love to be wrong about this!)